Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer

Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer

Abstract Background The dreadful prognosis of nonmuscle invasive bladder cancer mainly results from the delay in recognition of individuals with a high risk of progression. Thus, the emphasis of this work lies in developing valuable biomarkers that is conducive to accurately predicting the progressi...

Full description

Bibliographic Details
Main Authors:	Jiawei Shi, Pu Zhang, Lilong Liu, Xiaobo Min, Yajun Xiao
Format:	Article
Language:	English
Published:	Wiley 2019-11-01
Series:	Molecular Genetics & Genomic Medicine
Subjects:	biomarkers CENPF nonmuscle invasive bladder cancer (NMIBC) progression weighted gene coexpression network analysis (WGCNA)
Online Access:	https://doi.org/10.1002/mgg3.982

Similar Items

Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial
by: Jun Zhou, et al.
Published: (2019-01-01)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
by: Jingbo Sun, et al.
Published: (2019-10-01)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
by: Nada Humayun-Zakaria, et al.
Published: (2019-03-01)

Comprehensive Gene Expression Analysis in NMIBC Using RNA-seq Reveals New Therapy Strategies
by: Xiaoliang Chen, et al.
Published: (2019-06-01)

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
by: Qiang Ruan, et al.
Published: (2021-02-01)

Recurrence and progression in nonmuscle invasive transitional cell carcinoma of urinary bladder treated with intravesical Bacillus Calmette–Guerin: A single center experience and analysis of prognostic factors
by: Shouki N Bazarbashi, et al.
Published: (2016-01-01)

Weighted Gene Coexpression Network Analysis Reveals Essential Genes and Pathways in Bipolar Disorder
by: Zhen-Qing Zhang, et al.
Published: (2021-03-01)

Comment on “Pooled analysis of Xpert bladder cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma”
by: Gopal Sharma
Published: (2021-08-01)

Linking Cell Dynamics With Gene Coexpression Networks to Characterize Key Events in Chronic Virus Infections
by: Mireia Pedragosa, et al.
Published: (2019-05-01)

Impact of maintenance therapy using a half dose of the bacillus Calmette–Guérin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study
by: Dai Koguchi, et al.
Published: (2020-12-01)

Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?
by: Ugur Yucetas, et al.
Published: (2020-01-01)

Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer
by: Antonella Cormio, et al.
Published: (2021-08-01)

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis
by: Zhao F, et al.
Published: (2017-11-01)

Single course of intravesical Bacillus Calmette–Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
by: Mohamed Bakr Mohamed, et al.
Published: (2020-01-01)

XBP1 negatively regulates CENPF expression via recruiting ATF6α to the promoter during ER stress
by: Tao Shen, et al.
Published: (2020-09-01)

Correlations of tumor depth and width with lymphovascular invasion in non-muscle invasive bladder cancer
by: Fitriana, M., et al.
Published: (2022)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
by: Ruiliang Wang, et al.
Published: (2021-06-01)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
by: Iris S. G. Brummelhuis, et al.
Published: (2021-01-01)

Utility and Safety of Repeat Transurethral Resection of Bladder Tumor Performed at a Tertiary Center
by: Anand Raja, et al.
Published: (2020-06-01)

Role of Repeat Transurethral Resection of Bladder Tumours after Primary Resection: A Retrospective Cross-sectional Study
by: Syed Sajjad Nazir, et al.
Published: (2021-02-01)

Sex-related differences in urothelial cell carcinoma of the bladder in Germany
by: Scheller T, et al.
Published: (2018-12-01)

LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis
by: Qi Chen, et al.
Published: (2020-08-01)

Management of non-muscle-invasive bladder cancer: quality of clinical practice guidelines and variations in recommendations
by: Jing Zhang, et al.
Published: (2019-11-01)

Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer
by: Sheng Li, et al.
Published: (2017-11-01)

Current Status of Radical Cystectomy on High-risk Nonmuscle Invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2021-05-01)

Nonmuscle myosin 2 proteins encoded by Myh9, Myh10, and Myh14 are uniquely distributed in the tubular segments of murine kidney
by: Karla L. Otterpohl, et al.
Published: (2017-12-01)

Research Progress in Risk Stratification Tools and Prognostic Models for Non-muscle-invasive Bladder Cancer
by: ZHAO Jiahong, et al.
Published: (2020-04-01)

Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer
by: Itamar Getzler, et al.
Published: (2018-10-01)

Nonmuscle myosin IIA is involved in recruitment of apical junction components through activation of α-catenin
by: Masayuki Ozawa
Published: (2018-05-01)

Identification of Key Pathways and Genes Related to the Development of Hair Follicle Cycle in Cashmere Goats
by: Jianfang Wang, et al.
Published: (2021-01-01)

Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
by: Ma C, et al.
Published: (2016-08-01)

Effect of Age on Outcome of High-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated with Second Transurethral Resection and Maintenance Bacillus Calmette-Guerin Therapy
by: Sümer Baltacı, et al.
Published: (2016-09-01)

High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
by: Danijel Sikic, et al.
Published: (2021-06-01)

Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity
by: Bedeir Ali-El-Dein, et al.
Published: (2013-01-01)

Cost‑effectiveness analysis of hexaminolevulinate (Hexvix®) guided cystoscopy in Non‑Muscle Invasive Bladder Cancer patients (NMIBC) in Italy
by: Craig Bennison, et al.
Published: (2014-09-01)

Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis
by: Nakahara K, et al.
Published: (2019-04-01)

Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
by: Matteo Giulietti, et al.
Published: (2018-10-01)

Co-Expression Network Analysis Identifies Possible Hub Genes in Aging of the Human Prefrontal Cortex
by: César Payán-Gómez, MD, MSc, PhD, et al.
Published: (2019-06-01)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
by: Jan-Friedrich Jokisch, et al.
Published: (2015-01-01)

Cell Biological and Microfabrication Approaches Towards the Understanding of Transmigration and Nonmuscle Myosin II Assembly
by: Breckenridge, Mark T.
Published: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ka99ce9m5odf00h14sjas2aien